Ghent University Academic Bibliography

Your filters: cql: author="Schotsaert, Michael" or (type any "bookEditor issueEditor" and editor="Schotsaert, Michael")

Add to list
- Journal Article
- A1
- open access
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice

Sonia Jangra, Alexander Lamoot, Gagandeep Singh, Gabriel Laghlali (UGent) , Yong Chen (UGent) , Tingting Ye (UGent) , Adolfo García-Sastre, Bruno De Geest (UGent) and Michael Schotsaert

(2024) FRONTIERS IN IMMUNOLOGY. 15.
Add to list
- Journal Article
- A1
- open access
Lipid nanoparticle encapsulation empowers poly(I:C) to activate cytoplasmic RLRs and thereby increases its adjuvanticity

Alexander Lamoot, Sonia Jangra, Gabriel Laghlali, Prajakta Warang, Gagandeep Singh, Lauren A. Chang, Seok‐Chan Park, Gagandeep Singh, Kim Deswarte (UGent) , Zifu Zhong (UGent) , et al.

(2024) SMALL. 20(10).
Add to list
- Journal Article
- A1
- open access
Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia

Lauren A. Chang, Angela Choi, Raveen Rathnasinghe, Prajakta Warang, Moataz Noureddine, Sonia Jangra, Yong Chen (UGent) , Bruno De Geest (UGent) and Michael Schotsaert

(2023) FRONTIERS IN IMMUNOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine

Sonia Jangra, Gabriel Laghlali, Angela Choi, Raveen Rathnasinghe, Yong Chen (UGent) , Soner Yildiz, Lynda Coughlan, Adolfo García-Sastre, Bruno De Geest (UGent) and Michael Schotsaert

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

Teodora-Eugenia Oltean, Lorena Ibanez (UGent) , Tatyana Divert (UGent) , Tine Ysenbaert (UGent) , Hannelore Van Eeckhoutte, Vera Goossens (UGent) , Michael Schotsaert (UGent) , Ken Bracke (UGent) , Bert Schepens (UGent) , Jonathan Maelfait (UGent) , et al.

(2022) CELL DEATH & DISEASE. 13(3).
Add to list
- Journal Article
- A1
- open access
Characterization of SARS-CoV-2 spike mutations important for infection of mice and escape from human immune sera

Raveen Rathnasinghe, Sonia Jangra, Chengjin Ye, Anastasija Cupic, Gagandeep Singh, Carles Martínez-Romero, Lubbertus C. F. Mulder, Thomas Kehrer, Soner Yildiz, Angela Choi, et al.

(2022) NATURE COMMUNICATIONS. 13(1).
Add to list
Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine**

Sonia Jangra, Jana De Vrieze, Angela Choi, Raveen Rathnasinghe, Gabriel Laghlali, Annemiek Uvyn (UGent) , Simon Van Herck (UGent) , Lutz Nuhn, Kim Deswarte (UGent) , Zifu Zhong (UGent) , et al.

(2021) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 60(17). p.9467-9473
Add to list
- Journal Article
- A1
- open access
Current status of COVID-19 (pre)clinical vaccine development

Tingting Ye (UGent) , Zifu Zhong (UGent) , Adolfo Garcia-Sastre, Michael Schotsaert and Bruno De Geest (UGent)

(2020) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 59(43). p.18885-18897
Add to list
- Miscellaneous
- open access
Sterilizing immunity against SARS-CoV-2 infection in mice by a single-shot and modified imidazoquinoline TLR7/8 agonist-adjuvanted recombinant spike protein vaccine

Sonia Jangra, Jana De Vrieze, Angela Choi, Raveen Rathnasinghe, Gabriel Laghlali, Annemiek Uvyn (UGent) , Simon Van Herck (UGent) , Lutz Nuhn (UGent) , Kim Deswarte (UGent) , Zifu Zhong (UGent) , et al.

(2020) bioRxiv.
Add to list
- Journal Article
- A1
- open access
TIV vaccination modulates host responses to influenza virus infection that correlate with protection against bacterial superinfection

Angela Choi, Ioanna Christopoulou (UGent) , Xavier Saelens (UGent) , Adolfo García-Sastre and Michael Schotsaert

(2019) VACCINES. 7(3).

Academic Bibliography

Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice

Lipid nanoparticle encapsulation empowers poly(I:C) to activate cytoplasmic RLRs and thereby increases its adjuvanticity

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia

RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

Characterization of SARS-CoV-2 spike mutations important for infection of mice and escape from human immune sera

Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine**

Current status of COVID-19 (pre)clinical vaccine development

Sterilizing immunity against SARS-CoV-2 infection in mice by a single-shot and modified imidazoquinoline TLR7/8 agonist-adjuvanted recombinant spike protein vaccine

TIV vaccination modulates host responses to influenza virus infection that correlate with protection against bacterial superinfection

Contents

Support

Contact